Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study (Q59624365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Satish K Garg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Darren K McGuire

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Sangeeta Sawhney

1 reference

2 April 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

Paul Strumph

1 reference

2 April 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

Timothy S Bailey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Phillip Banks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Wendy S Lane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Pablo Lapuerta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Anne L Peters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

John Reed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

24 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

1970-1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

Insulin pump therapy: a meta-analysis

2 April 2020

cites work

1 reference

12 December 2020

Assessing psychosocial distress in diabetes: development of the diabetes distress scale

1 reference

12 December 2020

Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes.

1 reference

12 December 2020

Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.

1 reference

12 December 2020

LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.

1 reference

12 December 2020

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects

1 reference

12 December 2020

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

1 reference

12 December 2020

Outpatient glycemic control with a bionic pancreas in type 1 diabetes

1 reference

12 December 2020

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.

1 reference

12 December 2020

Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.

1 reference

12 December 2020

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor

1 reference

12 December 2020

Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release

1 reference

12 December 2020

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.

1 reference

12 December 2020

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry

1 reference

12 December 2020

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

1 reference

12 December 2020

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition

1 reference

12 December 2020

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)

1 reference

12 December 2020

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

1 reference

12 December 2020

THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES.

1 reference

12 December 2020

Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes

1 reference

12 December 2020

Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes

1 reference

12 December 2020

A Population-Based Study of All-Cause Mortality and Cardiovascular Disease in Association With Prior History of Hypoglycemia Among Patients With Type 1 Diabetes.

1 reference

12 December 2020

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.

1 reference

12 December 2020

Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries

1 reference

12 December 2020

The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

1 reference

12 December 2020

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

1 reference

12 December 2020

Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes

1 reference

12 December 2020

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial

1 reference

12 December 2020

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries.

1 reference

12 December 2020

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

1 reference

12 December 2020

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

1 reference

12 December 2020

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

1 reference

12 December 2020

Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th

1 reference

12 December 2020

14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018.

1 reference

12 December 2020

Sodium-glucose co-transporter 2 (SGLT2) inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes

1 reference

12 December 2020

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC18-0343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

PubMed publication ID

29937430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29937430%20AND%20SRC:MED&resulttype=core&format=json